Save information for later
Sign Up

Learn About Chondrosarcoma

View Main Condition: Brain Tumor

What is the definition of Chondrosarcoma?
Chondrosarcoma is a rare, slow-growing form of bone cancer that develops in the bones or the cartilage. The cartilage is the connective tissue from which most bones develop. Chondrosarcomas appear in bones or cartilage at the base of the skull, arms, scapula, ribs, pelvis, knee, femur (thighbone), or tibia.
What are the symptoms of Chondrosarcoma?
Symptoms of chondrosarcoma depend on the cartilage or bone that is involved and include the appearance of a large mass on the affected bone, swelling and pressure surrounding the mass, muscle wasting, gradually increasing pain not relieved with rest, constant pain that worsens at night, and fracture of the affected bone. A chondrosarcoma that appears on the spine may cause weakness, numbness, and an inability to control the release of urine (incontinence) or bowels.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Chondrosarcoma?
Treatment for chondrosarcoma depends on a patient’s age, overall health, medical history, the stage and location of the cancer, and may include surgery to remove the tumor, bone reconstructive surgery, amputation, radiation therapy, chemotherapy, and physical therapy.
Who are the top Chondrosarcoma Local Doctors?
Hematology Oncology | Oncology | Hematology
Hematology Oncology | Oncology | Hematology

St Lukes Clinic-Treasure Valley LLC

608 W Hays St, 
Boise, ID 
 2.1 mi
Accepting New Patients

William Kreisle is a Hematologist Oncology specialist and an Oncologist in Boise, Idaho. Dr. Kreisle and is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Follicular Lymphoma, Childhood Acute Myeloid Leukemia, Multiple Myeloma, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Kreisle is currently accepting new patients.

Oncology | Hematology | Hematology Oncology
Oncology | Hematology | Hematology Oncology

St Lukes Clinic-Treasure Valley LLC

100 E Idaho St, 
Boise, ID 
 2.3 mi
Accepting New Patients

Norman Zuckerman is an Oncologist and a Hematologist in Boise, Idaho. Dr. Zuckerman and is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Ovarian Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, Testicular Yolk Sac Tumor, and Bone Marrow Aspiration. Dr. Zuckerman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Oncology | Hematology Oncology | Hematology
Oncology | Hematology Oncology | Hematology

St Lukes Clinic-Treasure Valley LLC

100 E Bannock St, 
Boise, ID 
 2.3 mi
Accepting New Patients
Offers Telehealth

Travis Williams is an Oncologist and a Hematologist Oncology provider in Boise, Idaho. Dr. Williams and is rated as an Experienced provider by MediFind in the treatment of Chondrosarcoma. His top areas of expertise are Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Williams is currently accepting new patients.

What are the latest Chondrosarcoma Clinical Trials?
A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma

Summary: Randomized, blinded, placebo-controlled, Phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma patients.

Match to trials
Find the right clinical trials for you in under a minute
Get started
The Safety, Tolerability and Biodistribution of a Single Intravenous Administration of Two Zirconium-89 Labelled Vartumabs (F8scFV or C9scFv) in Patients with Solid Tumors - a Phase 0, Open Label, PET/CT Molecular Imaging Basket Trial

Summary: VARTUTRACE is a first-in-human PET/CT molecular imaging study in patients with solid tumors. This study will investigate the biodistribution and pharmacology of two antibody fragments binding oncofetal Chondroitin Sulfate (CS). Oncofetal CS are tumor-specific carbohydrate motifs present in proteoglycans and identified by VAR2 Pharmaceuticals as expressed during fetal development. Oncofetal CS reap...